FindTrial
Sign In

The study on evaluation and treatment of severe pancreatitis by using contrast-enhanced ultrasound and interventional ultrasound

The study on evaluation and treatment of severe pancreatitis by using contrast-enhanced ultrasound and interventional ultrasound

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044530
Enrollment
Unknown
Registered
2021-03-23
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pancreatitis

Interventions

The experimental group:Puncture and drainage of peripancreatic effusion guided by ultrasound
The control group:none

Sponsors

Tianjin Nankai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients complied with the guidelines for diagnosis and treatment of pancreatic surgery group of Chinese Medical Association of Surgery (2014) : Clinical diagnosis of severe acute pancreatitis, acute, persistent abdominal pain, serum amylase activity increased >= 3 times the upper limit of the normal value, and has one of the following: local complications (pancreatic necrosis, pseudocyst, pancreatic abscess); Organ failure; Ranson score >= 3; APACHE II score of 8 or higher; The CT grades were D and E.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
Scope of effusion;The thickness of the pancreas;—

Countries

China

Contacts

Public ContactLi Liang

Tianjin Nankai Hospital

iqliliang@163.com+86 22-27435919

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026